SecBot SecBot
PRESS-RELEASE ·Filed Apr 1, 2026

PROF

Profound Medical Corp.
NEUTRAL
Impact 3/10
Horizonweeks Processed7mo ago WireGlobeNewswire
Press release · FDA
Actionable Insight • Neutral

Monitor for follow-up data releases or peer-reviewed publication of CAPTAIN trial results, which could support reimbursement expansion or broader adoption. This event alone does not justify a trading move.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$6.53
T+0 close · Apr 1, 2026 · via day close
Latest settled
+0.92%
T+60 · $6.59
Vs SPY
−12.46%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 1 $6.53entry
  2. T+1 · 8mo ago −1.53%α −1.61% · $6.43
  3. T+5 · 7mo ago −1.38%α −5.14% · $6.44
  4. T+20 · 7mo ago +0.31%α −9.42% · $6.55
  5. T+60 · 5mo ago +0.92%α −12.46% · $6.59
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Profound Medical announced that its TULSA-PRO system and the MRI-guided TULSA Procedure will be featured in multiple presentations at the 2026 Society of Interventional Radiology (SIR) Annual Meeting, including data from the CAPTAIN trial and real-world clinical experience. While the event increases visibility for the technology, no new clinical results, regulatory decisions, or commercial updates were disclosed. This is a promotional awareness event, not a material clinical or regulatory milestone.

Key Facts

  • TULSA-PRO and TULSA Procedure will be highlighted in multiple oral and featured presentations at SIR 2026 Annual Meeting in Toronto (April 11–15, 2026).
  • Presentations include CAPTAIN trial data (Level 1 evidence), real-world experience, and a meta-analysis of oncologic and functional outcomes.
  • No new clinical data, FDA decisions, or commercial updates were released.
  • The event is a scientific conference presentation, not a regulatory or commercial catalyst.

Financial Impact

Minimal near-term financial impact; potential long-term benefit from increased physician awareness and adoption.

revenuemarket awareness

Risk Factors

  • Increased visibility does not guarantee adoption or reimbursement.
  • Forward-looking statements in the release are speculative and not guaranteed.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3266591

US Market Status

Market Closed · Opens Wed (9h 59m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 1, 2026